Evidence map›Paper›PMID 37680148›Full record

ArticleCombinatorial chemistry & high throughput screening2025

Elucidating Anti-aging and Antioxidant Activity of

Minjee Kim, Eunji Lee, Young Bong Kim

Abstract read
PubMed Publisher
In one paragraph

Article in Combinatorial chemistry & high throughput screening, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.6field-weighted citation impact, top 30% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Minjee KimDepartment of Biomedical Science and Engineering, Konkuk University, Seoul, 05029, Republic of Korea.
Eunji LeeDepartment of Biomedical Science and Engineering, Konkuk University, Seoul, 05029, Republic of Korea.
Young Bong KimDepartment of Biomedical Science and Engineering, Konkuk University, Seoul, 05029, Republic of Korea.
Konkuk University · KR

Funding

National Research Foundation of Korea (NRF), by the Korean government (MSIT) NRF-2022R1A6A3A01086057
6 · The paper itself

Abstract

introductionHydnocarpus anthelmintica (HA) has been traditionally used for treating leprosy and is known for its antioxidant and anti-inflammatory activities. The aim of this study was to investigate the active compounds and targets of HA extracts, involved in oxidative stress and skin aging. The active compounds and targets of HA extracts were identified using network pharmacology.

methodThe pathway study was conducted using the Kyoto Encyclopedia of Genes and Genomes (KEGG) database. HA semen was measured for its in-vitro antioxidant activity using 2,2-diphenyl- 1-picrylhydrazyl (DPPH) assay and anti-aging activities using collagenase, elastase, and tyrosinase assays. A total of 21 intersecting core targets were identified from 8 compounds, 51 action targets, and 1810 skin aging and oxidative stress-associated target genes.

resultA compound-target network was constructed, and 3 compounds (luteolin, beta-carotene and genkwanin), and 4 hub genes (TP53, HSP90AA1, JUN, and MAPK1) were identified. The KEGG pathway study revealed that the compounds were correlated with PI3K-Akt, p53, HIF-1, and MAPK signaling.

conclusionThe results of in-vitro experiments showed the effect of HA extract on oxidative stress reduction and collagenase inhibition. We discovered two main active compounds, luteolin and β-carotene, that may be involved in p53 and MAPK signaling, and showed HA extract activity against oxidative stress and collagenase.

Indexed as

AntioxidantsCosmeceuticalsPlant ExtractsSkin AgingBiphenyl CompoundsComputer SimulationHumansOxidative StressPancreatic ElastasePicrates1,1-diphenyl-2-picrylhydrazylAntioxidantsBiphenyl CompoundsCosmeceuticalsPancreatic ElastasePicratesPlant ExtractsHydnocarpus anthelminticamolecular dockingnetwork pharmacologyoxidative stressROS.skin aging

Identifiers

PMID37680148
OpenAlexW4386531280

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.